return to news
  1. Stock Market Highlights: Markets settle lower dragged by IT stocks ahead of US Fed decision

Stock Market Highlights: Markets settle lower dragged by IT stocks ahead of US Fed decision

Upstox

5 mins read | Updated on September 18, 2024, 16:53 IST

Twitter Page
Linkedin Page
Whatsapp Page

SUMMARY

Benchmark equity indices SENSEX and NIFTY ended lower on Wednesday, after hitting fresh record high levels during the morning trade, dragged by IT stocks as investors preferred to book profits ahead of the keenly-awaited US Fed's decision on interest rates.

card-img
  1. Markets settle lower dragged by IT stocks ahead of US Fed decision

    Benchmark equity indices SENSEX and NIFTY ended lower on Wednesday, after hitting fresh record high levels during the morning trade, dragged by IT stocks as investors preferred to book profits ahead of the keenly-awaited US Fed's decision on interest rates.

    The 30-share BSE SENSEX dropped 131.43 points or 0.16% to settle at 82,948.23. During the day, it climbed 246.72 points or 0.29% to scale a new all-time intra-day peak of 83,326.38.

    The NSE NIFTY also declined 41 points or 0.16% to close at 25,377.55. During the day, it advanced 63.65 points or 0.25% to hit a fresh intra-day lifetime high of 25,482.20.

    September 18, 2024, 16:03 PM

  2. Tata Power arm bags 400 MW hybrid project from MSEDCL

    Tata Power Renewable Energy, a subsidiary of Tata Power, on Wednesday said it has secured a 400 MW wind-solar hybrid project from Maharashtra State Electricity Distribution Company Ltd (MSEDCL).

    Tata Power Renewable Energy Ltd (TPREL) has successfully secured a Letter of Award (LoA) from MSEDCL, a wholly-owned entity under the Maharashtra government, for the development of a 400 MW wind-solar hybrid project in Maharashtra, a statement said.

    September 18, 2024, 14:39 PM

  3. Lupin signs patent licence pact with Takeda for novel gastrointestinal drug in Indian market

    Home-grown pharma major Lupin Ltd on Wednesday said it has entered into a non-exclusive patent licence agreement with Takeda Pharmaceutical Company Ltd to commercialise Vonoprazan tablets, a novel gastrointestinal drug, in the Indian market.

    Under the terms of this agreement, Takeda has granted Lupin non-exclusive patent licensing rights to commercialise Vonoprazan in India, the company said in a regulatory filing.

    September 18, 2024, 14:09 PM

  4. TCS inks pact with McDonald's Philippines to digitise operations for its 760+ outlets

    Tata Consultancy Services (TCS) on Wednesday said it has signed a two-year partnership with global fast-food chain McDonald's to standardise and digitise IT operations for over 760 of its restaurants in Phillippines.

    September 18, 2024, 13:54 PM

  5. Stock Market Live Updates: Markets trade lower; NIFTY50 down 0.17%, SENSEX down 70 points

    Benchmark indices traded lower on Wednesday, with NIFTY50 down 0.17% and SENSEX shedding 70 points. In the NIFTY50 space, 36 stocks declined. TCS, HCLTech and Tech Mahindra were among the top losers.

    September 18, 2024, 13:23 PM